ALKEM LABS LTD FDA Approval ANDA 213039

ANDA 213039

ALKEM LABS LTD

FDA Drug Application

Application #213039

Application Sponsors

ANDA 213039ALKEM LABS LTD

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL2.5MG/ML0CLOBAZAMCLOBAZAM

FDA Submissions

UNKNOWN; ORIG1AP2021-05-06STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213039
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLOBAZAM","activeIngredients":"CLOBAZAM","strength":"2.5MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/06\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-05-06
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.